NorthCoast Asset Management’s Biogen BIIB Stock Holding History

NorthCoast Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.14M	Hold	4,006	–	–	0.04%	242
2021 Q2	$1.39M	Sell	4,006 -34	-0.8%	-$10.3K	0.05%	218
2021 Q1	$1.13M	Sell	4,040 -1,388	-26%	-$374K	0.05%	220
2020 Q4	$1.33M	Sell	5,428 -3,107	-36%	-$802K	0.06%	178
2020 Q3	$2.42M	Sell	8,535 -2,345	-22%	-$654K	0.12%	116
2020 Q2	$2.91M	Buy	10,880 +7,198	+195%	+$2.16M	0.17%	94
2020 Q1	$1.17M	Buy	+3,682	New	+$1.12M	0.07%	140
2019 Q4	–	Sell	-10,347	Closed	-$2.41M	–	241
2019 Q3	$2.41M	Sell	10,347 -180	-2%	-$41.9K	0.16%	86
2019 Q2	$2.46M	Sell	10,527 -48,461	-82%	-$11.2M	0.16%	93
2019 Q1	$13.9M	Sell	58,988 -90	-0.2%	-$28.3K	0.91%	46
2018 Q4	$17.8M	Sell	59,078 -1,390	-2%	-$444K	1.35%	27
2018 Q3	$21.4M	Sell	60,468 -19,696	-25%	-$6.78M	1.32%	30
2018 Q2	$23.3M	Sell	80,164 -462	-0.6%	-$130K	2.21%	17
2018 Q1	$22.1M	Buy	80,626 +78,336	+3,421%	+$24.3M	2.04%	20
2017 Q4	$729K	Buy	+2,290	New	+$735K	0.07%	143
2016 Q2	–	Sell	-137,775	Closed	-$35.9M	–	169
2016 Q1	$35.9M	Sell	137,775 -16,912	-11%	-$4.47M	3.05%	12
2015 Q4	$47.4M	Sell	154,687 -20,043	-11%	-$5.76M	3.08%	13
2015 Q3	$51M	Sell	174,730 -2,665	-2%	-$880K	2.78%	13
2015 Q2	$71.7M	Buy	177,395 +7,811	+5%	+$3.13M	3.43%	6
2015 Q1	$71.6M	Sell	169,584 -73,215	-30%	-$28.9M	3.35%	7
2014 Q4	$82.4M	Buy	+242,799	New	+$78.5M	4.05%	1
2013 Q3	–	Sell	-3,709	Closed	-$798K	–	163
2013 Q2	$798K	Buy	+3,709	New	+$793K	0.06%	87

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NorthCoast Asset Management's BIIB Position: Q3 2021 in Review

NorthCoast Asset Management held its Biogen (BIIB) position steady in Q3 2021 at 4,006 shares worth $1.14M. The position accounts for 0.04% of the portfolio, ranked #242.

NorthCoast Asset Management first reported a position in BIIB in Q2 2013 and has held it in 22 quarters since. The position peaked at $82.4M in Q4 2014. 1,040 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

NorthCoast Asset Management held 4,006 shares of Biogen worth $1.14M as of Q3 2021.
NorthCoast Asset Management left its Biogen share count unchanged in Q3 2021.
Biogen made up 0.04% of NorthCoast Asset Management's portfolio in Q3 2021, its #242 holding.
NorthCoast Asset Management first reported a position in Biogen in Q2 2013 and has held it in 22 quarters since.
NorthCoast Asset Management's Biogen position peaked at $82.4M in Q4 2014.
1,040 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.